ArticleThoracic cancer2026

Efficacy of Osimertinib in Patients With Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations.

Yuko Iida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.